These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7587035)

  • 21. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia.
    Norrby SR; Petermann W; Willcox PA; Vetter N; Salewski E
    Scand J Infect Dis; 1998; 30(4):397-404. PubMed ID: 9817522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative assessment of efficacy of the 3d generation cephalosporins, ceftriabol, and claforan, in patients with community-acquired pneumonia].
    Vakhrushev IaM; Starodubtseva OI
    Klin Med (Mosk); 2009; 87(7):53-5. PubMed ID: 19705794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are third-generation cephalosporins associated with a better prognosis than amoxicillin-clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
    Batard E; Javaudin F; Kervagoret E; Caruana E; Le Bastard Q; Chapelet G; Goffinet N; Montassier E
    Clin Microbiol Infect; 2018 Nov; 24(11):1171-1176. PubMed ID: 29964229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.
    Adu A; Armour CL
    Drugs; 1995 Sep; 50(3):423-39. PubMed ID: 8521766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cephalosporins of the third generation in therapy of children with severe infections].
    Samsygina GA
    Antibiot Khimioter; 2000; 45(12):32-3. PubMed ID: 11212493
    [No Abstract]   [Full Text] [Related]  

  • 26. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.
    Korting HC; Abeck D
    Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital.
    Gutensohn A; Bunz D; Frighetto L; Jewesson P
    Chemotherapy; 1991; 37 Suppl 3():15-21. PubMed ID: 1909228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic prophylaxis in the surgical treatment of peritrochanteric fractures: a comparative trial between two cephalosporins.
    Karachalios T; Lyritis GP; Hatzopoulos E
    Chemotherapy; 1990; 36(6):448-53. PubMed ID: 2292207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
    Lode H; Eller J; Raffenberg M; Mauch H
    Clin Microbiol Infect; 2000; 6 Suppl 3():87-9. PubMed ID: 11449664
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
    Oksi J; Nikoskelainen J; Viljanen MK
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):715-9. PubMed ID: 9865985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
    Amir J; Harel L; Eidlitz-Markus T; Varsano I
    Clin Pediatr (Phila); 1996 Dec; 35(12):629-33. PubMed ID: 8970755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
    Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic use in nursing home-acquired pneumonia.
    Bobba RK; Bollu M; Arsura EL
    J Am Geriatr Soc; 2007 Nov; 55(11):1893-4; author reply 1894-5. PubMed ID: 17979913
    [No Abstract]   [Full Text] [Related]  

  • 35. Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study.
    Leu HS; Lasserre R
    Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):36-42. PubMed ID: 7767852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nosocomial pneumonia: comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations.
    Fernández-Guerrero M; Gudiol F; Rodriguez-Torres A; Arnau C; Valdés L; Vallvé C
    Infection; 1991; 19 Suppl 6():S320-5. PubMed ID: 1791077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
    Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
    Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open, controlled, randomized study on the efficacy and safety of cefodizime single daily dose versus two daily doses and versus ceftriaxone single daily dose in patients with acute purulent bronchitis and acute purulent exacerbation of chronic bronchitis.
    Zanussi C; Cocuzza G
    J Chemother; 1995 Dec; 7(6):535-42. PubMed ID: 8667039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins.
    Smyth ET; Barr JG; O'Neill CA; Hogg GM
    Pharmacoeconomics; 1995 Dec; 8(6):541-50. PubMed ID: 10160082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amoxycillin/potassium clavulanate in inpatients with bronchopulmonary infections].
    Nonikov VE; Konstantinova TD; Lenkova NI; Minaev VI; Ritchik LA
    Antibiot Khimioter; 1997; 42(10):15-8. PubMed ID: 9412397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.